Ccms, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 207 Harriman St, Alexander, IA 50420 Phone: 641-580-0423 Fax: 509-461-5656 |
News Archive
Octapharma has launched a phase 3, multi-center superiority study to compare the effectiveness of PANZYGA (immune globulin intravenous, human - ifas) 10% Liquid Preparation versus placebo in patients with pediatric acute-onset neuropsychiatric syndrome (PANS).
It is time we act proactively to minimize the effect of climate change on our health, say the researchers behind a new review published in Environment International. To do this, more cross-disciplinary collaboration is needed to predict how climate change will alter the outbreak and spread of infectious diseases.
A team of US-based scientists has recently conducted a robust high-throughput screening to identify potential entry inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The screening identifies calpeptin as a potent and highly specific inhibitor of SARS-CoV-2 and its variants. The study is currently available on the bioRxiv* preprint server.
There have been roughly three global pandemic influenza outbreaks each century for the past four hundred years, each of which have resulted in larger numbers of infections and deaths.
› Verified 6 days ago